NCT06579105 Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. Status COMPLETED Phase PHASE2
NCT06571383 STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06557811 Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction Status NOT_YET_RECRUITING Phase PHASE4
NCT06546384 GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease Status NOT_YET_RECRUITING Phase NA
NCT06541509 Mechanisms of Semaglutide Therapy in Heart Failure Patients Status RECRUITING Phase PHASE1/PHASE2
NCT06534411 A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06507475 Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type 2 Diabetes Status COMPLETED Phase N/A
NCT06499857 Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation Status RECRUITING Phase PHASE3
NCT06489457 The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity Status COMPLETED Phase PHASE3
NCT06478550 A Research Study to Understand How People With Type 2 Diabetes Take Ozempic® and if the Ozempic®App Helps Them Stay on This Treatment Status COMPLETED Phase N/A
NCT06475586 Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT06468748 The Effects of Semaglutide on Body Composition and Performance in Military Personnel Status WITHDRAWN Phase PHASE4
NCT06409130 Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease Status COMPLETED Phase PHASE2
NCT06403761 Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT06396416 Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2 Status RECRUITING Phase PHASE4
NCT06390501 The Effect of Weekly Semaglutide Treatment on Energy Expenditure Status COMPLETED Phase NA
NCT06388187 A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight Status COMPLETED Phase PHASE3
NCT06361823 Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment Status NOT_YET_RECRUITING Phase PHASE3
NCT06354101 The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study. Status WITHDRAWN Phase N/A